ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the multidrug resistance protein (MRP) gene.

Glutathione-S-transferase-catalyzed conjugation of glutathione (GSH) to aflatoxin B1-8,9-epoxide plays an important role in preventing binding of this ultimate carcinogen to target macromolecules. Once formed, the aflatoxin B1-epoxide-GSH conjugates are actively extruded from the cell by an unidentified ATP-dependent export pump or pumps. Two possible candidates for this GSH conjugate pump are the 190-kDa multidrug resistance protein (MRP) and the 170-kDa P-glycoprotein. Both proteins belong to the ATP-binding cassette superfamily of transmembrane transport proteins and confer resistance to a similar spectrum of natural-product drugs. Using membrane vesicles from MRP-transfected cells, we found that MRP transports GSH conjugates of both the endo-isomers and exo-isomers of aflatoxin B1-8,9-epoxide in an ATP-dependent, osmotically sensitive manner (V(max) = 180 pmol/mg/min, K(m) = 189 nM). Membrane vesicles from P-glycoprotein-overexpressing cells showed very low levels of transport. MRP-mediated transport was inhibited by an MRP-specific monoclonal antibody and by a variety of GSH derivatives and cholestatic steroid glucuronides. ATP-dependent transport of unmodified aflatoxin B1 by MRP-enriched membrane vesicles was low but markedly enhanced in the presence of 5 mM GSH, even though GSH conjugates of aflatoxin B1 were not formed by the vesicles. These data demonstrate that MRP is capable of energy-dependent transport of aflatoxin B1 and its GSH conjugates and suggest a potential protective role for MRP in mammalian chemical carcinogenesis.

[1]  S. Cole,et al.  Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. , 1996, Biochemical pharmacology.

[2]  T. Massey,et al.  Glutathione S-transferase-catalyzed conjugation of bioactivated aflatoxin B1 in rabbit lung and liver. , 1996, Toxicology and applied pharmacology.

[3]  D. Hipfner,et al.  Location of a protease-hypersensitive region in the multidrug resistance protein (MRP) by mapping of the epitope of MRP-specific monoclonal antibody QCRL-1. , 1996, Cancer research.

[4]  K. Tew,et al.  ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Keppler,et al.  cDNA Cloning of the Hepatocyte Canalicular Isoform of the Multidrug Resistance Protein, cMrp, Reveals a Novel Conjugate Export Pump Deficient in Hyperbilirubinemic Mutant Rats* , 1996, The Journal of Biological Chemistry.

[6]  T. Massey.  The 1995 Pharmacological Society of Canada Merck Frosst Award. Cellular and molecular targets in pulmonary chemical carcinogenesis: studies with aflatoxin B1. , 1996, Canadian journal of physiology and pharmacology.

[7]  S. Cole,et al.  Biology of the multidrug resistance-associated protein, MRP. , 1996, European journal of cancer.

[8]  S. Cole,et al.  Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter. , 1996, Molecular pharmacology.

[9]  S. Cole,et al.  Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. , 1996, The Journal of biological chemistry.

[10]  S. Cole,et al.  ATP-dependent 17-Estradiol 17-(-D-Glucuronide) Transport by Multidrug Resistance Protein (MRP) , 1996, The Journal of Biological Chemistry.

[11]  D. Keppler,et al.  Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. , 1996, Cancer research.

[12]  D. Keppler,et al.  ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. , 1996, The Biochemical journal.

[13]  P. Bosma,et al.  Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene , 1996, Science.

[14]  D. Meijer,et al.  Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. , 1995, Biochimica et biophysica acta.

[15]  N. Vermeulen,et al.  Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Role in bioactivation and detoxication mechanisms of xenobiotics. , 1995, Pharmacological reviews.

[16]  K. Cowan,et al.  Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation. , 1995, British Journal of Cancer.

[17]  K. Satoh,et al.  The high non-enzymatic conjugation rates of some glutathione S-transferase (GST) substrates at high glutathione concentrations. , 1995, Carcinogenesis.

[18]  P. Borst,et al.  Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  F. Sirotnak,et al.  Functional studies of P-glycoprotein in inside-out plasma membrane vesicles derived from murine erythroleukemia cells overexpressing MDR 3. , 1994, The Journal of Biological Chemistry.

[20]  G. M. Wilson,et al.  Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. , 1994, Cancer research.

[21]  D. Hipfner,et al.  Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. , 1994, Cancer research.

[22]  D. Keppler,et al.  The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. , 1994, The Journal of biological chemistry.

[23]  F. Baas,et al.  The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. Williams,et al.  Indole-3-carbinol induces a rat liver glutathione transferase subunit (Yc2) with high activity toward aflatoxin B1 exo-epoxide. Association with reduced levels of hepatic aflatoxin-DNA adducts in vivo. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[25]  Kevin D. Raney,et al.  DNA adduction by the potent carcinogen aflatoxin B1 : mechanistic studies , 1994 .

[26]  D. Hipfner,et al.  Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. , 1994, Cancer research.

[27]  E. Grill,et al.  ATP-dependent glutathione S-conjugate 'export' pump in the vacuolar membrane of plants , 1993, Nature.

[28]  F. Baas,et al.  Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. , 1993, Cancer research.

[29]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[30]  G. C. Yeh,et al.  A new functional role for P-glycoprotein: efflux pump for benzo(alpha)pyrene in human breast cancer MCF-7 cells. , 1992, Cancer research.

[31]  T. Ishikawa,et al.  The ATP-dependent glutathione S-conjugate export pump. , 1992, Trends in biochemical sciences.

[32]  F. Sharom,et al.  Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells. , 1992, Biochimica et biophysica acta.

[33]  I. West.  What determines the substrate specificity of the multi-drug-resistance pump? , 1990, Trends in biochemical sciences.

[34]  T. Ishikawa,et al.  Evidence for leukotriene C4 transport mediated by an ATP‐dependent glutathione S‐conjugate carrier in rat heart and liver plasma membranes , 1989, FEBS letters.

[35]  D. Eaton,et al.  Effects of modulation of hepatic glutathione on biotransformation and covalent binding of aflatoxin B1 to DNA in the mouse. , 1988, Toxicology and applied pharmacology.

[36]  I. Pastan,et al.  ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[37]  I. Pastan,et al.  Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. Lotlikar,et al.  Comparative kinetic studies on aflatoxin B1-DNA binding and aflatoxin B1-glutathione conjugation with rat and hamster livers in vitro. , 1984, Carcinogenesis.

[39]  J. Hayes,et al.  The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. , 1995, Critical reviews in biochemistry and molecular biology.

[40]  E. Gallagher,et al.  Mechanisms of aflatoxin carcinogenesis. , 1994, Annual review of pharmacology and toxicology.

[41]  I. Pastan,et al.  Function and regulation of the human multidrug resistance gene. , 1993, Advances in cancer research.

[42]  S. Thorgeirsson,et al.  Multidrug resistance gene family and chemical carcinogens. , 1991, Pharmacology & therapeutics.

[43]  J. Hayes,et al.  Contribution of the glutathione S-transferases to the mechanisms of resistance to aflatoxin B1. , 1991, Pharmacology & therapeutics.

[44]  N. Nibbering,et al.  Mechanistic studies , 1979, Philosophical Transactions of the Royal Society of London. Series A, Mathematical and Physical Sciences.